IRIS
IACOBELLI, SIMONA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.099
AS - Asia 2.753
EU - Europa 1.890
Continente sconosciuto - Info sul continente non disponibili 477
SA - Sud America 427
AF - Africa 61
OC - Oceania 7
Totale 24.714
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.969
SG - Singapore 1.185
CN - Cina 425
BR - Brasile 343
RU - Federazione Russa 319
IT - Italia 312
KR - Corea 282
HK - Hong Kong 272
UA - Ucraina 202
SE - Svezia 180
DE - Germania 168
IE - Irlanda 162
VN - Vietnam 162
FI - Finlandia 155
GB - Regno Unito 133
BD - Bangladesh 108
FR - Francia 100
JP - Giappone 74
CA - Canada 70
ID - Indonesia 52
IN - India 43
CZ - Repubblica Ceca 34
NL - Olanda 31
AR - Argentina 27
AT - Austria 22
CO - Colombia 22
IQ - Iraq 19
TR - Turchia 17
ES - Italia 16
MX - Messico 15
PH - Filippine 14
JM - Giamaica 13
PK - Pakistan 13
PL - Polonia 13
CL - Cile 12
GH - Ghana 12
IR - Iran 12
ZA - Sudafrica 12
BE - Belgio 11
JO - Giordania 10
CR - Costa Rica 9
EC - Ecuador 9
SA - Arabia Saudita 9
EU - Europa 8
MA - Marocco 8
AU - Australia 7
EE - Estonia 7
NG - Nigeria 7
NI - Nicaragua 7
NP - Nepal 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
DZ - Algeria 6
UZ - Uzbekistan 6
GR - Grecia 5
MY - Malesia 5
UY - Uruguay 5
EG - Egitto 4
KE - Kenya 4
KZ - Kazakistan 4
NO - Norvegia 4
PA - Panama 4
VE - Venezuela 4
IL - Israele 3
LT - Lituania 3
PY - Paraguay 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
DK - Danimarca 2
GT - Guatemala 2
HN - Honduras 2
KW - Kuwait 2
LB - Libano 2
LK - Sri Lanka 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
RO - Romania 2
RS - Serbia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BZ - Belize 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GP - Guadalupe 1
HT - Haiti 1
IS - Islanda 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
MW - Malawi 1
SN - Senegal 1
SO - Somalia 1
ST - Sao Tome e Principe 1
Totale 24.242
Salva come PNG Salva come JPEG
Città #
Woodbridge 4.564
Wilmington 4.296
Houston 3.962
Fairfield 657
Ashburn 656
Singapore 589
San Jose 458
Ann Arbor 385
Seattle 278
Chandler 271
Hong Kong 265
Cambridge 245
Creede 202
Santa Clara 192
Dublin 155
Jacksonville 144
Medford 135
Council Bluffs 128
Beijing 104
Helsinki 96
New York 95
Rome 88
Los Angeles 78
The Dalles 75
Moscow 64
Lawrence 60
Lauterbourg 59
Dearborn 57
Buffalo 55
Ho Chi Minh City 51
Tokyo 51
North Bergen 49
Milan 44
Hanoi 42
Zhengzhou 42
Nanjing 38
Jakarta 37
London 31
San Diego 31
Brno 29
Redwood City 26
Shanghai 26
São Paulo 26
Nuremberg 25
Philadelphia 25
Dallas 24
Chicago 22
Phoenix 22
Scottsdale 20
Petaluma 18
Naples 17
Redondo Beach 15
Rio de Janeiro 15
Toronto 15
Boardman 14
Orem 14
Atlanta 13
Belo Horizonte 13
Brasília 13
Accra 12
Chennai 12
Las Vegas 12
Seoul 12
Brussels 11
Mülheim 11
Warsaw 11
Bogotá 10
Charlotte 10
Norwalk 10
Amman 9
Amsterdam 9
Baghdad 9
Brooklyn 9
Montreal 9
Stockholm 9
Turku 9
Denver 8
Haiphong 8
Kingston 8
Lappeenranta 8
Manila 8
Miami 8
San José 8
Sunnyvale 8
Wuhan 8
Birmingham 7
Bologna 7
Hangzhou 7
Kilburn 7
Lagos 7
Manchester 7
Munich 7
Nanchang 7
Pereira 7
Roppongi 7
Vienna 7
Washington 7
Austin 6
Columbus 6
Guangzhou 6
Totale 19.569
Salva come PNG Salva come JPEG
Nome #
Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial) 720
Centre characteristics and procedure-related factors have an impact on outcomes of allogeneic transplantation for patients with CLL: a retrospective analysis from the European Society for Blood and Marrow Transplantation (EBMT) 561
Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation 517
M4 acute myeloid leukemia: the role of eosinophilia and cytogenetics in treatment response and survival. The GIMEMA experience. 493
Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study 486
Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study 479
Salvage use of allogeneic stem cell transplantation after reduced intensity conditioning from unrelated donors in multiple myeloma. A study by the Plasma Cell Disorders subcommittee of the EBMT Chronic Malignancies Working Party 456
Superiority of the Triple Combination of Bortezomib-Thalidomide-Dexamethasone Over the Dual Combination of Thalidomide-Dexamethasone in Patients With Multiple Myeloma Progressing or Relapsing After Autologous Transplantation: The MMVAR/IFM 2005-04 Randomized Phase III Trial From the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation 453
Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease? 448
Efficacy and outcome of autologous transplantation in rare myelomas 446
Early administration of donor lymphocyte infusions upon molecular relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia: a study by the Chronic Malignancies Working Party of the EBMT. 444
Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party 444
Multiple time scales in multi-state models 443
Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloid leukemia 442
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia 442
Tandem autologous/reduced-intensity allogeneic stem cell transplantation versus autologous transplantation in myeloma: long-term follow-up 441
Stem cell transplantation for chronic myeloid leukemia in children 440
Outcome of patients developing GvHD after DLI given to treat CML relapse: a study by the chronic leukemia working party of the EBMT 440
Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant Research 440
Assessment of the role of timing of second transplantation in multiple myeloma by multistate modeling 439
Partially anaortic clampless off-pump coronary artery bypass prevents neurologic injury compared to on-pump coronary surgery: a propensity score-matched study on 286 patients 437
Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group 437
Liposomal daunorubicin versus standard daunorubicin: long term follow-up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia 429
Current practices used for the prevention of central venous catheter-associated infection in hematopoietic stem cell transplantation recipients: a survey from the Infectious Diseases Working Party and Nurses' Group of EBMT 426
Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation 425
Protective Environment for Hematopoietic Cell Transplant (HSCT) Recipients: The Infectious Diseases Working Party EBMT Analysis of Global Recommendations on Health-Care Facilities 422
Influence of pre-existing invasive aspergillosis on allo-HSCT outcome: a retrospective EBMT analysis by the Infectious Diseases and Acute Leukemia Working Parties 416
High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation 414
Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow Transplantation 412
Autologous/reduced-intensity allogeneic stem cell transplantation versus autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study 410
Low tumor burden is associated with early B-cell reconstitution and is a predictor of favorable outcome after non-myeloablative stem cell transplant for chronic lymphocytic leukemia 409
Efficacy and outcome of allogeneic transplantation in IgD and nonsecretory myeloma. A report on behalf of the Myeloma Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation 405
Survival probabilities with time-dependent treatment indicator: quantities and non-parametric estimators 403
Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation 402
The Cox shared frailty model with log-skew-normal frailties 394
Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: A study from the chronic malignancies working party of the EBMT 392
Melphalan 140mg/M2 Or 200mg/M2 For Autologous Transplantation In Myeloma: Results From The Collaboration To Collect Autologous Transplant Outcomes In Lymphoma And Myeloma (CALM) Study. A Report By The EBMT Chronic Malignancies Working Party 390
Length of stay in different drug using states: lifestyles of problem and recreational drug consumers 389
Allogenic hematopoietic stem cell transplantation in patients with polycythemia or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: report from the MPN subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation 387
Incidence of Second Primary Malignancies after Autologous Transplantion for Multiple Myeloma in the Era of Novel Agents. 384
Primary plasma cell leukemia and autologous stem cell transplantation 378
Evaluation of short- and long-term response to treatment in GIMEMA protocol for Acute Myeloid Leukaemia 363
Impact of complete remission before and after allogeneic and autologous transplantation in multiple myeloma: results from the EBMT NMAM2000 prospective trial 362
Association of aplastic anaemia and lymphoma: a report from the severe aplastic anaemia working party of the European Society of Blood and Bone Marrow Transplantation. 359
Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome Patients with a 5q Deletion 355
Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma. 342
Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma 332
Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita 273
Allogeneic transplantation in multiple myeloma - Does it still have a place? 180
EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL) 170
Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy 164
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia 139
Autoimmune cytopenias (AIC) following allogeneic haematopoietic stem cell transplant for acquired aplastic anaemia: a joint study of the Autoimmune Diseases and Severe Aplastic Anaemia Working Parties (ADWP/SAAWP) of the European Society for Blood and Marrow Transplantation (EBMT) 131
Comparison of autologous and allogeneic hematopoietic cell transplantation strategies in patients with primary plasma cell leukemia, with dynamic prediction modelling 130
Pollen variability in Quercus L. species and relative systematic implications 130
Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors 120
Prognostic impact of early-versus-late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation: Results from the CALM study by the CMWP of the EBMT 115
Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes 113
An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT 112
Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT 112
Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation 111
Conditioning-based outcomes after allogeneic transplantation for myeloma following a prior autologous transplant (1991-2012) on behalf of EBMT CMWP 110
Complement C3 inhibition in severe COVID-19 using compstatin AMY-101 108
Allogeneic and syngeneic hematopoietic cell transplantation in patients with amyloid light-chain amyloidosis: a report from the European Group for Blood and Marrow Transplantation 103
Impact of T-cell depletion strategies on outcomes following hematopoietic stem cell transplantation for idiopathic aplastic anemia: a study on behalf of the European blood and marrow transplant severe aplastic anemia working party. 99
Analyzing differences between restricted mean survival time curves using pseudo-values 99
Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMT 97
Results from a multicenter, noninterventional registry study for multiple myeloma patients who received stem cell mobilization regimens with and without plerixafor 97
Determinants of survival in myelofibrosis patients undergoing allogeneic hematopoietic cell transplantation 96
IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study 93
Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma 89
Upfront stem cell transplantation for newly diagnosed multiple myeloma with del(17p) and t(4;14): a study from the CMWP-EBMT 89
Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study 89
Role of Age and Hematopoietic Cell Transplantation-Specific Comorbidity Index in Myelodysplastic Patients Undergoing an Allotransplant: A Retrospective Study from the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation 87
Long-term survival of 1338 MM patients treated with tandem autologous vs. autologous-allogeneic transplantation 86
Benefit and timing of second transplantations in multiple myeloma: clinical findings and methodological limitations in a European Group for Blood and Marrow Transplantation registry study 86
Intercontinental study on pre-engraftment and post-engraftment Gram-negative rods bacteremia in hematopoietic stem cell transplantation patients: risk factors and association with mortality 85
Impact of donor-derived CD34+infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT 85
Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia 83
ZAP-70 expression in acute lymphoblastic leukemia: association with the E2A/PBX1 rearrangement and the pre-B stage of differentiation and prognostic implications 81
Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP 80
The effect of prior exposure to imatinib on transplant-related mortality 79
Outcomes and toxicity of allogeneic HCT in CML patients previously treated with second generation TKIs: a prospective non-interventional study from the Chronic Malignancy Working Party of EBMT 77
Plain language summary of RACE study results: addition of eltrombopag to standard treatment of severe aplastic anemia 71
Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors 70
Pharmacogenetic analysis of liver toxicity after busulfan/cyclophosphamide-based allogeneic hematopoietic stem cell transplantation 68
Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients – A clinical trial to registry data comparison 66
Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma 62
Statistical methods in HSCT and cellular therapies 62
The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants 58
Reduced-intensity conditioning for myeloma: lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioning 57
Role of stem cell transplantation in myeloma 54
Totale 24.714
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.411
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.411
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022506 0 0 0 0 21 51 43 26 34 55 57 219
2022/20231.379 88 77 40 77 76 205 411 229 78 18 44 36
2023/2024386 34 18 29 28 45 54 34 22 32 28 8 54
2024/20251.762 50 399 184 110 15 172 114 66 189 174 129 160
2025/20263.070 197 210 362 156 172 126 373 407 393 236 203 235
2026/20271.375 161 140 615 456 3 0 0 0 0 0 0 0
Totale 24.714